Premium
How men view genetic testing for prostate cancer risk: findings from focus groups
Author(s) -
Doukas DJ,
Fetters MD,
Coyne JC,
McCullough LB
Publication year - 2000
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1034/j.1399-0004.2000.580303.x
Subject(s) - focus group , genetic testing , prostate cancer , affect (linguistics) , anticipation (artificial intelligence) , ethnic group , descriptive statistics , qualitative research , medicine , informed consent , family medicine , psychology , cancer , alternative medicine , pathology , social science , statistics , mathematics , communication , marketing , artificial intelligence , sociology , computer science , anthropology , business
Objective: To determine the values, beliefs, and attitudes that influence a man's intention to undergo or defer genetic testing for prostate cancer risk.
Design: Qualitative, using focus group interviews – 12 focus groups were conducted to identify key values and beliefs about genetic testing for prostate cancer risk in anticipation of its future availability.
Setting: Medium‐sized, mid‐west, US city.
Participants: Community sample of 90 lay men of diverse educational, ethnic, and age backgrounds.
Analysis: Descriptive statistics and immersion/crystallization to identify themes and sub‐themes.
Results: The major areas of concern were distilled into the following themes: beliefs about consequences, expectations, benefits for patients, beliefs about barriers, and susceptibility concerns.
Conclusion: Identifying these men's values will help health professionals anticipate the informational and ethical needs of patients in the informed consent process. Men will need to understand how such testing may affect their planning regarding future prostate health, and how medical information is used outside of the physician–patient relationship.